ROLE OF INTERFERONS IN REGULATION OF OSTOGENIC AND OSTEORESORPTIVE PROCESSES
Abstract
Bone tissue preserves high metabolic activity during all time of its life. Homeostasis of bone tissue is provided by fine balance between its formation by osteoblasts and its resorption by osteoclasts. There are complex regulatory interrelations between cells of bone differon and. system of interferons, the peculiarities of production of which mediate disturbances of osteoformating and. resorptive components of osteo metabolism at various pathological conditions. The review presents literature data on the role of interferons in regulation of osteogenous and. osteoresorptive processes which opens up the prospective of aimed application of interferons preparations with the purpose of restoration of immunologic imbalance and. bone tissue homeostasis.
About the Authors
L. A. Dmitrieva
Scientific Center of Reconstructive and Restorative Surgery SB RAMS
Russian Federation
Russian Federation
E. Yu. Korshunova
Irkutsk State Medical University
Russian Federation
Russian Federation
V. F. Lebedev
Irkutsk State Medical University
Russian Federation
Russian Federation
References
1. Кетлинский С.А., Симбирцев А.С. Цитокины. — СПб.: Фолиант, 2008. — 549 с.
2. Abraham A.K., Ramanathan M., Weinstock-Guttman B., Mager D.E. Mechanisms of interferon-beta effects on bone homeostasis // Biochem. Pharmacol. -2009. - Vol. 77, N 12. - P. 1757-1762.
3. Borovecki F., Pecina-Slaus N., Vukicevic S. Biological mechanisms of bone and cartilage remodeling - genomic perspective // International Orthopaedics (SICOT). - 2007. - Vol. 31 - P. 799-805.
4. Fukada S.Y., Silva T.A., Garlet G.P., Rosa A.L. et al. Factors involved in the T helper type 1 and type
5. cell commitment and osteoclast regulation in inflammatory apical diseases // Oral Microbiol. Immunol. - 2009. - Vol. 24 (1). - P. 25-31.
6. Gao Y., Grassi F., Ryan M.R., Terauchi M. et al. IFN-y stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation // J. Clin. Invest. - 2007. - Vol. 117. - P. 122-132.
7. Gowen M., MacDonald B.R., Russell G.G. Actions of recombinant human y-interferon and tumor necrosis factor a on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro // Arthritis Rheum. - 1988. - Vol. 31. - P. 1500-1507.
8. Gruber H.E., Hoelscher G., Ingram J.A., Chow Y. et al. 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro // J. Spine (Phila Pa 1976). - 2008. - Vol. 33 (7). - P. 755-765.
9. Ha H., Lee J.H., Kim H.N., Kwak H.B. et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta // Immunol. - 2008. -Vol. 180 (3). - P. 1382-1389.
10. Horowitz M.C., Lorenzo J.A. B Lymphocytes and the skeleton // Ann NY Acad. Sci. - 2007. -Vol. 1117. - P. 82-93.
11. Horowitz M.C., Lorenzo J.A. Immunologic regulation of bone development // Adv. Exp. Med. Biol. - 2007. - Vol. 602. - P. 47-56.
12. Hukkanen M., Hughes F.J., Buttery L.D., Gross S.S. et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity // Endocrinology. -1995. - Vol. 136 (12). - P. 5445-5453.
13. Iba K., Takada J., Yamashita T. Prospects of treatment using interferon for bone diseases // Nippon Rinsho. - 2006. - Vol. 64 (7). - P. 1275-1280.
14. Jr Key L.L., Ries W.L., Rodriguiz R.M., Hatcher H.C. Recombinant human interferon у therapy for osteopetrosis // J. Pediatr. - 1992. - Vol. 121. -P. 119-124.
15. Jr Key L.L., Rodriguiz R.M., Willi S.M., Wrigth N.M. et al. Long-term treatment of osteopetrosis with recombinant human interferon у // N. Engl. J. Med. - 1995. - Vol. 332. - P. 1594-1599.
16. Kalvakolanu D.V., Borden E.C. Interferons: cellular and molecular biology of their actions // In: Bertion, JR., editor. Encyclopedia Cancer. - 2002. -Vol. 2. - P. 511-521.
17. Kawase Y., Hoshino T., Yokota K. Bone malformations in interleukin-18 transgenic mice // J. Bone Miner Res. - 2003. - Vol. 18. - P. 975-983.
18. Li H., Gade P., Xiao W., Kalvakolanu D.V The Interferon Signaling Network and Transcription Factor C/EBP-p // Cell Mol. Immunol. - 2007. -Vol. 4 (6). - P. 407-418.
19. Liu C.J., Chang E., Yu J., Carlson C.S. et al. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation // J. Biol. Chem. - 2005. -Vol. 280 (4). - P. 2788-2796.
20. Lorenzo J., Horowitz M., Choi Y. Osteoimmunology: interactions of the bone and immune system // Endocr. Rev. - 2008. - Vol. 29. - P. 403-440.
21. Luan Y, Yu X.P., Yang N., Frenkel S. et al. Р204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins // Mol. Biol. Cell. - 2008. -Vol. 19 (5). - P. 2113-2126.
22. Makiishi-Shimobayashi C., Tsujimura T., Iwasaki T., Yamada N. et al. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells // Biochem. Biophy. Res. Comm. - 2001. -Vol. 281. - P. 361 -366.
23. Nanes M.S., McKoy W.M., Marx S.J. Inhibitory effects of tumor necrosis factor-a and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) // Endocrinology. -1989. - Vol. 124. - P. 339-345.
24. Nii A., Reynolds D.A., Young H.A., Ward J.M. Osteochondrodysplasia occurring in transgenic mice expressing interferon-g // Vet. Pathol. - 1997. -Vol. 34. - P. 431 -441.
25. Oreffo R.O.C., Romberg S., Virdi A.S., Joyner C.J. et al. Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro // J. Cell. Biochem. - 1999. - Vol. 74. - P. 372-385.
26. Orozco A., Gemmell E., Bickel M., Seymour G.J. Interleukin 18 and periodontal disease // J. Dent. Res. - 2007. - Vol. 86. - P. 586-593.
27. Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization // Cell Biochem. - 2006. -Vol. 98 (4). - P. 706-714.
28. Ruiz C., Perez E., Garcfa-Martfnez O., Diaz-Rodrigues L. et al. Expression of cytokines IL-4, IL-12, IL-15, IL-18, and IFNgamma and modulation by different growth factors in cultured human osteoblast-like cells // J. Bone Miner Metab. - 2007. - Vol. 25 (5). -P. 286-292.
29. Sakai S., Takaishi H., Matsuzaki K. et al. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression // J. Bone Miner Metab. - 2009. -Vol. 27 (6). - P. 643-652.
30. Takahashi N., Mundy G.R., Roodman G.D. Recombinant human interferon-y inhibits formation of human osteoclast-like cells // J. Immunol. - 1986. -Vol. 137. - P. 3544-3549.
31. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology // Mol. Med. - 2005. - Vol. 83 (3). - P. 170-179.
32. Takayanagi H., Kim S., Matsuo K., Suzuki H. et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta // Nature. - 2002. -Vol. 416. - P. 744-749.
33. Takayanagi H., Ogasawara K., Hida S., Chiba T. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-y // Nature. - 2000. - Vol. 408. - P. 600-605.
34. Takayanagi H., Sato K., Takaoka A., Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism // Immunol. Rev. - 2005. - Vol. 208. - P. 181-193.
35. Yamada N., Niwa S., Tsujimura T., Iwasaki T. et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity // Bone. - 2002. - Vol. 30. - P. 901-908.
36. Yamamura M., Kawashima M., Taniai M., Yamauchi H. et al. Interferon-y-inducing activity of interleukin-18 in the joint with rheumatoid arthritis // Arthritis Rheum. - 2001. - Vol. 44. -P. 275-285.
37. Yoshihara R., Shiozawa S., Imai Y., Fujita T. Tumor necrosis factor alpha and interferon gamma inhibit proliferation and alkaline phosphatase activity of human osteoblastic Sa-OS-2 cell line // Lymphokine Res. - 1990. - Vol. 9. - P. 59-66.
Review
For citations:
Dmitrieva L.A., Korshunova E.Yu., Lebedev V.F. ROLE OF INTERFERONS IN REGULATION OF OSTOGENIC AND OSTEORESORPTIVE PROCESSES. Acta Biomedica Scientifica. 2012;(5(2)):136-140. (In Russ.)
Views:
333
Email this article 
